In the final meeting of the Facilitated Dialogue on Closed Generics (15 November 2023), the participants evaluated their experience with Facilitated Dialogue, offering their feedback on various aspects of dialogue's structure and process. The participants' feedback is captured in the document below:
* Please note that these inputs represent the individual opinions of the Facilitated Dialogue participants, and do not represent the views of their appointing Supporting Organization or Advisory Committees.
